期刊文献+

对比增强前后SWI在脑星形细胞肿瘤分级中的诊断价值 被引量:4

The diagnostic value of pre-and post-contrast susceptibility weighted imaging(SWI) in grading brain astrocytic tumors
暂未订购
导出
摘要 目的:探讨对比增强前后磁共振磁敏感加权成像(susceptibility weighted imaging,SWI)在脑星形细胞肿瘤分级中的应用价值。方法:选取手术病理证实前均行磁共振传统序列及SWI序列扫描的28例星形细胞肿瘤患者,观察肿瘤成像特点并进行比较;对SWI图像ITSS分级,分析其与肿瘤术后病理学分级之间的关系。结果:28例病灶,低级别组10例(Ⅰ级2例,Ⅱ级8例),高级别组18例(Ⅲ级10例,Ⅳ级8例)。18例病灶内显示ITSS,低级别组10例仅2例Ⅱ级肿瘤ITSS分级为1级,余均为0级;高级别组ITSS分级较高,8例多形性胶质母细胞瘤ITSS分级均为3级,间变性星形细胞瘤中2例ITSS分级为0级,3例为1级,3例为2级,2例为3级。ITSS分级和星形细胞肿瘤病理学级别的Spearman相关系数为0.854。结论:SWI序列作为传统序列的有效补充,增强前后SWI图像清晰显示瘤内出血和静脉血管,有助于肿瘤分级的评定,对于指导临床治疗和评估预后具有重要意义。 Objective:To estimate the diagnostic value of pre-and post-contrast-enhanced susceptibility-weighted imaging(SWI) in grading brain astrocytic tumors.Methods:A total of 28 patients(11 women,17 men) with brain astrocytic tumors included in this study.In addition to conventional magnetic resonance imaging,pre-and post-contrast-enhanced SWI were performed in all patients,whose images were analyzed between them.The intratumoral susceptibility signal intensity(ITSS) on SW images was graded,then correlation with the pathological gradation done.Results:To tally 28 tumors were found,and the number of low and high-grade tumors is 10(grade Ⅰ 2,grade Ⅱ8) and 18(grade Ⅲ 10,grade Ⅳ 8).ITSSs were found in 18 tumors,which included 2 low-grade tumors and 16 high-grade tumors.The grade of ITSS of the two low-grade tumors and 8 glioblastomas is 1 and 3,but the grade of ITSS of anaplastic astrocytomas is variable(the number of ITSS scale 0,1,2,3 is 2,3,3,1 respectively).Spearman correlation coefficient between ITSS scale and pathological gradation was 0.854.Conclusion:SWI clearly revealed the intratumoral blood production and small veins of astrocytic tumors,which may be instructive for clinical treatment and prognosis.
出处 《医学影像学杂志》 2011年第6期797-800,共4页 Journal of Medical Imaging
关键词 磁共振成像 磁敏感加权成像 星形细胞肿瘤 Magnetic resonance imaging Susceptibility weighted imaging Astrocytic tumors
  • 相关文献

参考文献11

  • 1Rauseher A, SedlacikJ, Barth M, et al. Magnetic suscepti- bility-weighted MR Phase imaging of the human brain [J]. Am J Neuroradiol, 2005, 26: 736-742.
  • 2Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging J] [J]. J Magn Reson Imaging, 2005, 22:439-450.
  • 3Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses [J]. J Magn Reson Imaging, 2006, 24:41-51.
  • 4Park MJ, Kim HS, Jahng GH,et al. Semiquanthative assessment of intratumoral susceptibility signals using non con trast- enhanced high-field high-resolution susceptibility weighted imaging in patients with gliomas: comparison with MR perfusion imaging[J]. Am J Neuroradiol, 2009,30: 1402-1408.
  • 5Butowski NA, Sneed PK, Chang SM. Diagnosis and treat merit of recurrent high-grade astrocytoma [J]. J Clin OncoJ, 2006, 24: 1273-1280.
  • 6Schramm J, Blumcke I, Ostertag CB. Low-grade gliomascurrent concepts [J]. ZentralblNeurochir, 2006, 67:55-66.
  • 7Castillo M, Scatliff JH, Bouldin TW, et al. Radiologic pathologic correlation: intraeranial astrocytoma [J]. Am J Neuroradio;, 1992, 13: 1609-1616.
  • 8Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging [J]. Radiology, 1990,174: 411 -115.
  • 9Lin W, Mukherjee P, An HY, et al. Improving high rcsolution MR bold venognphic imaging using a T: reducing con trast agent [J]. J Magn Reson Imaging, 1999, 10:118-123.
  • 10Thomas B, SomasLmdaram S, Thamburaj K, ctal. Clinical applications of susceptibility weighted MR imaging of the brain: a pictorial review [J]. Neuroradiology, 2008, 50: 105-116.

同被引文献40

  • 1韩彤,崔世民.SWI原理及其在脑肿瘤评估和胶质瘤分级中的应用[J].国际医学放射学杂志,2011,34(1):15-20. 被引量:13
  • 2Hu LS,Baxter LC,Smith KA,et al.Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect:Direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements[J].Am J Neuroradiol,2009,30(3):552-558.
  • 3Park MJ,Kim HS,Jahng GH,et al.Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas:Comparison with MR perfusion imaging[J].Am J Neuroradiol,2009,30(7):1402-1408.
  • 4Hakyemez B,Erdogan C,Ercan I,et al.High-grade and low-grade gliomas:Differentiation by using perfusion MR imaging[J].Clin Radiol,2005,60(4):493-502.
  • 5Liao W,Liu Y,Wang X,et al.Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging[J].Acta Radiol,2009,50(2):217-225.
  • 6Vajkoczy P,Menger MD.Vascular microenvironment in gliomas[J].J Neurooncol,2000,50(1-2):99-108.
  • 7Hilario A,Ramos A,Perez-Nunez A,et al.The Added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas[J].AJNR Am J Neuroradiol,2011,29:1-7.
  • 8Weber MA,Zoubaa S,Schlieter M,et al.Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors[J].Neurology,2006,66(12):1899-1906.
  • 9Cha S,Knopp EA,Johnson G,et al.Intracranial mass lesions dynamic contrast enhanced susceptibility weighted echo planar perfusion MR imaging[J].Radiology,2002,223(1):11-29.
  • 10Sathornsumette S, Reardon DA, Desjardins A, et al.Molecular targeted therapy for malignant glioma.Cancer,2007, 110:13-24.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部